New York State Common Retirement Fund Portfolio holdings
AUM
$75.2B
1-Year Return
24.38%
This Quarter Return
+7.15%
1 Year Return
+24.38%
3 Year Return
+108.85%
5 Year Return
+192%
10 Year Return
+482.31%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$6.62B
Cap. Flow
% of AUM
-8.95%
Top 10 Holdings %
Top 10 Hldgs %
29.96%
Holding
3,439
New
40
Increased
393
Reduced
2,144
Closed
261
Top Buys
| 1 |
CNA Financial
CNA
|
+$53.9M |
| 2 |
Trip.com Group
TCOM
|
+$41.4M |
| 3 |
SW
Smurfit Westrock plc
SW
|
+$22.3M |
| 4 |
BioNTech
BNTX
|
+$21.3M |
| 5 |
WEX
WEX
|
+$20.5M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$376M |
| 2 |
Apple
AAPL
|
+$359M |
| 3 |
Microsoft
MSFT
|
+$278M |
| 4 |
Amazon
AMZN
|
+$147M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$112M |
Sector Composition
| 1 | Technology | 31.52% |
| 2 | Financials | 12.89% |
| 3 | Healthcare | 12.35% |
| 4 | Consumer Discretionary | 10.61% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Pacific Biosciences
PACB
$366M
| $36K | ﹤0.01% |
21,225
-65,400
| -75% | -$111K |
|
2902
Precigen
PGEN
$1.22B
| $36K | ﹤0.01% |
38,038
| – | – |
|
2903
Torrid Holdings
CURV
$179M
| $35K | ﹤0.01% |
9,002
| – | – |
|
2904
Galectin Therapeutics
GALT
$320M
| $35K | ﹤0.01% |
12,600
-32,900
| -72% | -$91.4K |
|
2905
Priority Technology Holdings
PRTH
$602M
| $35K | ﹤0.01% |
5,146
| – | – |
|
2906
Scilex Holding
SCLX
$177M
| $35K | ﹤0.01% |
1,071
| – | – |
|
2907
The Beauty Health Co
SKIN
$292M
| $35K | ﹤0.01% |
24,283
| – | – |
|
2908
Petco
WOOF
$1B
| $35K | ﹤0.01% |
7,797
-26,500
| -77% | -$119K |
|
2909
X4 Pharmaceuticals
XFOR
$76.1M
| $35K | ﹤0.01% |
1,721
| – | – |
|
2910
Zura Bio
ZURA
$134M
| $35K | ﹤0.01% |
8,547
| – | – |
|
2911
ProFrac Holding
ACDC
$695M
| $34K | ﹤0.01% |
5,019
| – | – |
|
2912
American Vanguard Corp
AVD
$152M
| $34K | ﹤0.01% |
6,322
| – | – |
|
2913
BCB Bancorp
BCBP
$149M
| $34K | ﹤0.01% |
2,727
| – | – |
|
2914
Gyre Therapeutics
GYRE
$742M
| $34K | ﹤0.01% |
2,700
-7,500
| -74% | -$94.4K |
|
2915
MBIA
MBI
$374M
| $34K | ﹤0.01% |
9,491
| – | – |
|
2916
Xperi
XPER
$275M
| $34K | ﹤0.01% |
3,700
-10,600
| -74% | -$97.4K |
|
|
QVCGB
2917
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
| $34K | ﹤0.01% |
160
| – | – |
|
2918
Cantaloupe
CTLP
$789M
| $33K | ﹤0.01% |
4,484
-15,100
| -77% | -$111K |
|
2919
Prime Medicine
PRME
$693M
| $33K | ﹤0.01% |
8,434
| – | – |
|
2920
ProKidney
PROK
$292M
| $33K | ﹤0.01% |
17,179
| – | – |
|
2921
ReposiTrak
TRAK
$306M
| $33K | ﹤0.01% |
1,800
-4,900
| -73% | -$89.8K |
|
|
ACRE
2922
Ares Commercial Real Estate
ACRE
$267M
| $32K | ﹤0.01% |
4,538
-14,600
| -76% | -$103K |
|
2923
AudioEye
AEYE
$160M
| $32K | ﹤0.01% |
1,400
-4,500
| -76% | -$103K |
|
|
AKYA
2924
DELISTED
Akoya BioSciences
AKYA
| $32K | ﹤0.01% |
11,802
| – | – |
|
2925
Golden Matrix Group
GMGI
$133M
| $32K | ﹤0.01% |
13,800
-26,400
| -66% | -$61.2K |
|